Metropolitan Life Insurance Company (MetLife)’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,482
Closed -$77.5K 849
2024
Q1
$77.5K Sell
23,482
-2,058
-8% -$4.61K ﹤0.01% 1189
2023
Q4
$53.9K Sell
25,540
-3,210
-11% -$6.24K ﹤0.01% 1409
2023
Q3
$61K Buy
28,750
+1,531
+6% +$4.16K ﹤0.01% 1291
2023
Q2
$87.4K Buy
27,219
+4,054
+18% +$11.5K ﹤0.01% 1087
2023
Q1
$50.3K Buy
23,165
+867
+4% +$2.46K ﹤0.01% 1391
2022
Q4
$54K Buy
22,298
+4,306
+24% +$9.65K ﹤0.01% 1427
2022
Q3
$42.1K Sell
17,992
-3,964
-18% -$8.88K ﹤0.01% 1578
2022
Q2
$34K Buy
21,956
+12,320
+128% +$17.4K ﹤0.01% 1740
2022
Q1
$13.1K Sell
9,636
-75,671
-89% -$84.4K ﹤0.01% 2226
2021
Q4
$104K Buy
85,307
+15,554
+22% +$22.3K ﹤0.01% 2452
2021
Q3
$95.6K Buy
69,753
+27,955
+67% +$37.3K ﹤0.01% 2550
2021
Q2
$58.9K Sell
41,798
-37,378
-47% -$54.4K ﹤0.01% 2659
2021
Q1
$125K Sell
79,176
-887
-1% -$1.58K ﹤0.01% 2324
2020
Q4
$127K Sell
80,063
-9,326
-10% -$17K ﹤0.01% 2225
2020
Q3
$156K Buy
89,389
+24,584
+38% +$45.5K ﹤0.01% 1935
2020
Q2
$141K Sell
64,805
-1,069
-2% -$1.6K ﹤0.01% 2041
2020
Q1
$78.4K Sell
65,874
-2,749
-4% -$3.37K ﹤0.01% 2183
2019
Q4
$93.3K Buy
68,623
+40,121
+141% +$58K ﹤0.01% 2371
2019
Q3
$37.9K Sell
28,502
-36,758
-56% -$49.2K ﹤0.01% 2518
2019
Q2
$92K Hold
65,260
﹤0.01% 2345
2019
Q1
$108K Buy
+65,260
New +$89.2K ﹤0.01% 2282
2018
Q4
Sell
-50,480
Closed -$88.8K 2558
2018
Q3
$88.8K Hold
50,480
﹤0.01% 2501
2018
Q2
$173K Buy
50,480
+3,792
+8% +$14.5K ﹤0.01% 2041
2018
Q1
$198K Buy
46,688
+14,697
+46% +$39.7K ﹤0.01% 1904
2017
Q4
$58K Sell
31,991
-65,189
-67% -$132K ﹤0.01% 2447
2017
Q3
$212K Sell
97,180
-14,269
-13% -$33.7K ﹤0.01% 2236
2017
Q2
$309K Hold
111,449
﹤0.01% 2047
2017
Q1
$253K Sell
111,449
-1,344
-1% -$2.87K ﹤0.01% 2117
2016
Q4
$233K Buy
112,793
+732
+0.7% +$1.54K ﹤0.01% 2252
2016
Q3
$253K Sell
112,061
-1,654
-1% -$4.29K ﹤0.01% 2182
2016
Q2
$305K Hold
113,715
﹤0.01% 2030
2016
Q1
$332K Buy
113,715
+839
+0.7% +$2.51K ﹤0.01% 1833
2015
Q4
$546K Hold
112,876
﹤0.01% 1571
2015
Q3
$312K Buy
112,876
+28,944
+34% +$105K ﹤0.01% 1956
2015
Q2
$359K Sell
83,932
-44,497
-35% -$176K ﹤0.01% 1980
2015
Q1
$484K Sell
128,429
-396
-0.3% -$1.34K ﹤0.01% 1581
2014
Q4
$419K Hold
128,825
﹤0.01% 1889
2014
Q3
$258K Buy
128,825
+58,060
+82% +$143K ﹤0.01% 2193
2014
Q2
$215K Sell
70,765
-46,291
-40% -$96.7K ﹤0.01% 2462
2014
Q1
$230K Sell
117,056
-3,585
-3% -$14.3K ﹤0.01% 2366
2013
Q4
$540K Hold
120,641
﹤0.01% 1765
2013
Q3
$382K Sell
120,641
-641
-0.5% -$1.05K ﹤0.01% 1944
2013
Q2
$172K Buy
+121,282
New +$132K ﹤0.01% 2441

Other funds holding GERN

Metropolitan Life Insurance Company (MetLife)'s GERN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Geron (GERN) in Q2 2024, closing a stake of 23,482 shares — an estimated $77.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GERN in Q2 2013 and held it in 43 quarters. The position peaked at $546K in Q4 2015. 239 funds tracked by Wall St. Rank hold GERN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Geron position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 23,482 Geron shares in Q2 2024, an estimated $77.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Geron in Q2 2013 and held it in 43 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Geron position peaked at $546K in Q4 2015.
  • 239 funds tracked by Wall St. Rank held Geron as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.